These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3727760)

  • 21. Increased levels of active pertussis toxin may aid a pertussis vaccine to pass the mouse body weight gain test.
    Horiuchi Y; Takahashi M; Asada S; Ishida S
    Biologicals; 1994 Sep; 22(3):243-8. PubMed ID: 7811458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and application of a novel ligand for affinity chromatography based removal of endotoxin from antibodies.
    McAllister LA; Hixon MS; Schwartz R; Kubitz DS; Janda KD
    Bioconjug Chem; 2007; 18(2):559-66. PubMed ID: 17315943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.
    Bolotin S; Harvill ET; Crowcroft NS
    Pathog Dis; 2015 Nov; 73(8):ftv057. PubMed ID: 26253079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and standardization of U.S. Standard Pertussis Vaccine, Lot No. 11.
    Jansen DL; Meade BD
    Biologicals; 1996 Dec; 24(4):363-70. PubMed ID: 9088553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Removal of endotoxin from culture supernatant of Bordetella pertussis with aminated poly(gamma-methyl L-glutamate) spherical beads.
    Hirayama C; Sakata M; Ohkura Y; Ihara H; Ohkuma K
    Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2106-9. PubMed ID: 1384997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [MEASUREMENT OF ENDOTOXIN VALUES IN CHICK EMBRYOS].
    KETYI I
    Zentralbl Bakteriol Orig; 1964 Apr; 192():373-84. PubMed ID: 14190321
    [No Abstract]   [Full Text] [Related]  

  • 27. Polymyxin B use does not ensure endotoxin-free solution.
    Kluger MJ; Singer R; Eiger SM
    J Immunol Methods; 1985 Oct; 83(1):201-7. PubMed ID: 2997328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further contributions to an improved pertussis vaccine: II. New findings in the development of a pertussis vaccine.
    Robbel L; Hungerer KD; Aktories K
    Behring Inst Mitt; 1984 Nov; (76):110-2. PubMed ID: 6098261
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficient endotoxin removal with a new sanitizable affinity column: Affi-Prep Polymyxin.
    Talmadge KW; Siebert CJ
    J Chromatogr; 1989 Aug; 476():175-85. PubMed ID: 2777972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of toxicities of acellular pertussis vaccine with whole cell pertussis vaccine in experimental animals.
    Sato Y; Sato H
    Dev Biol Stand; 1991; 73():251-62. PubMed ID: 1778317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of an acellular pertussis vaccine and its administration as a booster in healthy adults.
    Ruuskanen O; Noel A; Putto-Laurila A; Pêtre J; Capiau C; Delem A; Vandevoorde D; Simoen E; Teuwen DE; Bogaerts H
    Vaccine; 1991 Feb; 9(2):117-21. PubMed ID: 2058258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The preparation of A purified immunogenic pertactin from B. pertussis.
    El-Kady EM; Abu-Shady HM; Tohamy HS; Wahby AF
    Egypt J Immunol; 2007; 14(2):11-8. PubMed ID: 20306653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple discontinuity as a remarkable feature of the development of acellular pertussis vaccines.
    Wardlaw AC
    Vaccine; 1992; 10(10):643-51. PubMed ID: 1523873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel bivalent acellular pertussis vaccine based on the 69 kDa protein and FHA.
    Novotny P; Chubb AP; Cownley K; Charles IG
    Dev Biol Stand; 1991; 73():243-9. PubMed ID: 1778316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients.
    Isomura S; Suzuki S; Sato Y
    Dev Biol Stand; 1985; 61():531-7. PubMed ID: 3914964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic and hematologic effects and immune complex formation related to pertussis immunization.
    Mink CM; Uhari M; Blumberg DA; Knip M; Lewis K; Christenson PD; Toyoda M; Jordan SC; Levin SR; Cherry JD
    Pediatr Res; 1990 Apr; 27(4 Pt 1):353-7. PubMed ID: 2188202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptide.
    Vogel FR; Leclerc C; Schutze MP; Jolivet M; Audibert F; Klein TW; Chedid L
    Cell Immunol; 1987 Jun; 107(1):40-51. PubMed ID: 2438053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of endotoxin contamination of various crude vaccine materials by gram-negative bacteria using aminated poly(gamma-methyl L-glutamate) spherical particles.
    Sakata M; Kawai T; Ohkuma K; Ihara H; Hirayama C
    Biol Pharm Bull; 1993 Nov; 16(11):1065-8. PubMed ID: 7508778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. History of the development of pertussis vaccine.
    Pittman M
    Dev Biol Stand; 1991; 73():13-29. PubMed ID: 1778306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative biological activities of whole cell pertussis vaccine and a new acellular preparation.
    García-Sánz JA; Ruiz-Puente J; Jiménez-Paredes J; González-Pacheco M; Villalva-Posada H
    Vaccine; 1985 Mar; 3(1):23-6. PubMed ID: 4039870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.